Biologics in severe asthma: from precision phenotyping to clinical remission

The management of severe asthma has shifted to a precision medicine paradigm based on molecular phenotyping. Biologics have made clinical remission an attainable goal for many patients. Future research must focus on therapies for non-type 2 asthma, refining dynamic biomarkers, and establishing long-term disease-modifying effects.

Authors

Institutions

Publication Details

Journal
Journal of Asthma
Published
2026-03-14
DOI
https://doi.org/10.1080/02770903.2026.2644878
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biologics in severe asthma: from precision phenotyping to clinical remission

Daming Jiang, Minjie Wang
Journal of Asthma
Asthma and respiratory diseases
article

Biologics in severe asthma: from precision phenotyping to clinical remission

Daming Jiang, Minjie Wang
article en

Abstract

The management of severe asthma has shifted to a precision medicine paradigm based on molecular phenotyping. Biologics have made clinical remission an attainable goal for many patients. Future research must focus on therapies for non-type 2 asthma, refining dynamic biomarkers, and establishing long-term disease-modifying effects.

Journal of Asthma
Lianyungang Oriental Hospital (CN)
Zero hunger
Openalex Percentile: Top 21%
Asthma and respiratory diseases
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.